Maya Khalil, MD

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    National Cancer Institute
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Johnson & Johnson
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Amgen
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - Numab Therapeutics
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - Nitto BioPharma
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - Guardant
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Other - Cantargia
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie, Inc.
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027
  • Attribution:
    Other
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Astellas Pharma US, Inc
    Topic:
    Principal or sub investigator on clinical trial
    Date added:
    06/04/2024
    Date updated:
    06/04/2024
    Relationship end date:
    12/31/2027

Pages

Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology